This research identifies a specific 3D morphogenetic blueprint called Metastatic Trabecular Morphogenesis (MTM) that is essential for breast cancer spread. By utilizing single-cell RNA sequencing and AI-supported 3D imaging, scientists discovered that aggressive cancer cells reactivate fetal developmental programs to build complex, branching lattices of epithelial cords. These MTM-high states are not unique to distant sites but actually pre-exist in primary tumors that are destined to metastasize, serving as a powerful prognostic indicator. The study pinpointed the ETV1/4/5 transcription factors as the master regulators driving this structural expansion. Ultimately, the researchers found that this growth pattern depends on FGF signaling, suggesting a specific therapeutic vulnerability that could be targeted to stop lethal cancer outgrowth.

References:

• Caire R, Bordo R, Zanconato F, et al. A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer[J]. Cell, 2026.

The paper introduce SPTEdU-seq, a sophisticated spatial omics platform that simultaneously tracks newborn cell dynamics and maps the spatial total transcriptome. This innovative method utilizes optics-free detection via single-molecule probes and click chemistry, allowing researchers to study delicate cellular states without the damage caused by traditional imaging. By capturing both coding and non-coding RNAs as well as splicing isoforms, the technology provides a more comprehensive molecular view than previous techniques. The researchers demonstrated its utility by reconstructing regeneration trajectories in stroke models, tracing lineage maturation in embryos, and identifying heterogeneous splicing events in tumors. Ultimately, SPTEdU-seq offers a powerful framework for understanding complex cellular interactions and fate determinations within their native environments.

References:

• Niu H, Zhang S, Mao J, et al. SPTEdU-seq enables parallel optics-free newborn cell tracking and spatial total transcriptional dynamics in intact microenvironments[J]. Cell Stem Cell, 2026.

Researchers have developed a novel hydrogen-assisted transplantation strategy to overcome the significant challenges of cell death and phenotype loss in osteoarthritis treatment. By synthesizing titanium silicide (TSN) nanosheets, the team created a delivery system capable of providing a sustained two-month supply of hydrogen molecules directly to damaged joints. This persistent hydrogen release effectively neutralizes the toxic inflammatory microenvironment, preserving the health and functionality of transplanted chondrocyte microspheroids. In large-animal sheep models, this advanced H-MACsT therapy achieved remarkable results, including near-total cartilage regeneration and a successful reversal of disease progression within six months. The study demonstrates that hydrogen’s antioxidant and anti-inflammatory properties are vital for maintaining the survival of stem cell-derived grafts in pathological conditions. Consequently, this innovative approach offers a promising clinical pathway for treating refractory joint diseases and improving long-term success rates in regenerative medicine.

References:

• Chen S, Luo M, Chen S, et al. Preservation of chondrocyte microspheroids by local sustained hydrogen supply improves osteoarthritic cartilage repair[J]. Cell Stem Cell, 2026.

References:

• Cai Y, Yang Y, Yang J, et al. Perturb-seq uncovers pathological obstacles to direct cardiac reprogramming in vivo[J]. Cell Stem Cell, 2026.

References:

• Uenaka T, Napole A, Saha A D, et al. Prevention of transgene silencing during human pluripotent stem cell differentiation[J]. Cell Stem Cell, 2026, 33(3): 517-530. e8.

References:

• Touhara K K, Xu J, Castro J, et al. Parasites trigger epithelial cell crosstalk to drive gut–brain signalling[J]. Nature, 2026: 1-9.

This study investigates the epigenetic memory that remains in colonic stem cells long after inflammation from colitis has resolved. Researchers discovered that even when the tissue appears physically healed, stem cells retain a "memory" of the injury through lasting changes in chromatin accessibility and DNA methylation. This process is driven primarily by the AP-1 transcription factor, which stays active and is passed down through clonal lineages as cells divide. Crucially, this molecular memory primes stem cells for faster tumor growth when oncogenic mutations occur, providing a clear mechanistic link between chronic inflammation and cancer susceptibility. The authors also introduce SHARE-TRACE, a novel method to simultaneously track a cell's genetic expression, physical DNA structure, and ancestral history. Their findings suggest that targeting these persistent epigenetic alterations could offer new ways to prevent malignancy in patients with inflammatory diseases.

References:

• Nagaraja S, Ojeda-Miron L, Zhang R, et al. Epigenetic memory of colitis promotes tumour growth[J]. Nature, 2026: 1-10.

This research identifies a specialized interoreceptor in C. elegans that allows the enteric nervous system to detect and manage salt stress. Scientists discovered that a single pharyngeal neuron, known as I3, utilizes a specific ionotropic receptor complex—comprised of GLR-9 and GLR-7—to sense ingested cations directly within the gut. While cholinergic signaling from this neuron provides immediate protection against sudden high-salt exposure, peptidergic signaling involving the neuropeptide FLP-6 is required for long-term acclimatization. The study demonstrates that these internal sensory signals travel from the enteric network to distal tissues like the intestine and epidermis, where they reprogram the expression of stress-response genes. Ultimately, this mechanism reveals how a defined neural pathway maintains physiological homeostasis by defending the organism against the toxic effects of excessive salt.

References:

• Yeon J, Kim J, Sato K, et al. An enteric neuron ionotropic receptor regulates salt stress resistance[J]. Nature, 2026: 1-10.

This research identifies the aryl hydrocarbon receptor (AhR) as a critical molecular "brake" that limits the ability of the central nervous system to repair itself after injury. While neurons naturally activate AhR to manage cellular stress and maintain tissue integrity, this response inadvertently suppresses the metabolic and genetic programs required for axon regeneration. The study demonstrates that either genetic deletion or pharmacological inhibition of this receptor effectively flips a "stress-growth switch," redirecting neuronal resources toward protein synthesis and rapid regrowth. Experimental results in spinal cord and peripheral nerve injury models show that blocking AhR significantly improves both anatomical nerve repair and functional recovery. Furthermore, the findings reveal a complex interplay where AhR competes with other factors like HIF1α to coordinate the balance between survival and repair. Ultimately, the authors suggest that targeting the AhR pathway offers a promising new therapeutic strategy for treating neural damage.

References:

• Halawani D, Wang Y, Li J, et al. AhR inhibition promotes axon regeneration via a stress–growth switch[J]. Nature, 2026: 1-11.

References:

• Wang Q, Lee J H, Nachtrab G, et al. Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain[J]. Nature, 2026: 1-10.